BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Health Issues HCR

340B Drug Discount Program ---340B Program Reforms (Rep. C. Collins Discussion Draft) ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Program Implementation & Oversight Affordable Care Act - Repeal and Replace ---H.R. 1628: American Health Care Act ---The Better Care Reconciliation Act of 2017 (Senate Discussion Drafts) Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 Biodefense Research, Development, and Procurement Issues (Nonfunding) ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Implementation of Medical Countermeasures Innovation Act ---Tropical Disease Priority Review Voucher (PRV) Program ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Biosimilars ---Access to Samples for Testing ---Biosimilar User Fee Act Reauthorization and Implementation ---Brazil Biologics Regulations ---Coding ---India Biologics Regulations ---Interchangeability and Pharmacy Substitution ---Mexico Biologics Regulations ---Naming ---Patent Certification ---S. 974/H.R. 2212: CREATES Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Drug Evaluation and Review ---Compassionate Use/Expanded Access ---Expedited Pathways ---FDA Hiring Flexibility ---FDA Management and Financial Accountability ---FDA Proposed Rule on Changes to Drug Labeling ---Government Hiring Freeze ---Innovation Incentives ---Patient-Focused Drug Development ---Priority Review Voucher Programs ---Regulatory Reform & Modernization ---Reauthorization of the Prescription Drug User Fee Act ---Special Medical Use/Limited Population Drug ---Use of Real-World Evidence ---S.204 -H.R. 878: Rights to Try Act of 2017 ---S.456 - H.R. 1231: RACE for Children Act ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Drug Importation ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 771: Improving Access to Affordable Prescription Drugs ---S.469: Affordable and Safe Prescription Drug Importation Act ---Welch Amendment to: H.R. 2430: FDA Reauthorization Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Drug Manufacturing, Quality & Distribution ---Counterfeiting ---Drug Shortages ---Pharmacy Compounding & Oversight ---Supply Chain Integrity and Traceability Drug Pricing ---S. 771: Improving Access to Affordable Prescription Drugs ---S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Drug Product Communications ---The Medical Products Communications Act of 2017 (Rep. Griffith Discussion Draft) ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Funding for Antimicrobial Resistance Programs ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---Department of Defense Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for FDA ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for the Centers for Disease Control and Prevention Vaccine Programs ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Generic Drug Entry ---Access to Samples for Testing ---Generic Drug Application Review Reforms ---Incentives for Generic Entry ---H.R. 297: Increasing Competition in Pharmaceuticals Act ---H.R. 749: Lower Drug Costs through Competition Act ---S. 974/H.R. 2212: CREATES Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Medicaid ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates North American Free Trade Agreement (NAFTA) Renegotiation ---Pricing and Reimbursement Provisions ---Regulatory Harmonization ---IP Provisions Orphan Drug Issues ---RACE for Children Act (Discussion Draft) ---Tax Credit ---Technical Amendments ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Reimbursement for Innovative Products ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---S. 771: Improving Access to Affordable Prescription Drugs ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications UN High Level Commission on Access to Medicines ---IP Proposals Vaccines and Infectious Diseases ---H.R. 1628: American Health Care Act ---Vaccine and Anti-Microbial Resistance Product Development and Incentives ---Vaccine Injury Compensation Program ---Vaccine Safety Foreign Drug Data Protection Laws ---Israel Trade and Foreign Drug Price Controls

Contacted: U.S. Trade Representative (USTR); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); White House Office; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Treasury, Dept of; Natl Economic Council (NEC)

Bills named: S. 974 (115th), H.R. 1840 (115th), H.R. 749 (115th), S. 934 (115th), H.R. 878 (115th), H.R. 1231 (115th), H.R. 2430 (115th), H.R. 1628 (115th), S. 1348 (115th), S. 771 (115th), S. 456 (115th), S. 204 (115th), H.R. 297 (115th), H.R. 2212 (115th), S. 469 (115th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Amendment on GE Salmon Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---Labeling ---The One Health Act (Sen. Franken Discussion Draft) Review and Labeling of Food Derived From Biotechnology ---Implementation of Disclosure Law

Contacted: Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Environmental Protection Agency (EPA); Treasury, Dept of; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); White House Office; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Fuel/Gas/Oil FUE

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Farm Bill Reauthorization ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance ---Program Biomass Programs (Non-Funding) ---Farm Bill Reauthorization ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program Energy Basic Research Funding ---Advanced Research Projects Agency - Energy ---DOE Office of Science ---Energy and Water Development and Related Agencies Appropriations Act for FY 2018 Funding for Biofuels ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Department of Defense Appropriations Act for FY 2018 ---Department of Defense Funding of Advanced Biofuels ---Energy and Water Development and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization Funding for Biorefineries ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization ---H.R.2810: National Defense Authorization Act for 2018 ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program Renewable Fuel Standard ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Changes to the Point of Obligation under the RFS ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act ---RFS Reform ---Proposed Rule for 2018 Volumes

Contacted: U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); SENATE; Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); Natl Security Council (NSC); White House Office; Commerce, Dept of (DOC); Treasury, Dept of

Bills named: S. 517 (115th), H.R. 1311 (115th), H.R. 2810 (115th)

Agriculture AGR

Biomass Programs (Non-Funding) ---Farm Bill Reauthorization ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program EPA Regulations on Biotechnology ---Efficient Science-Based Review of Biotech Products ---H.R. 1029: Pesticide Registration Improvement Extension Act of 2017 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization Funding for the USDA ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Genetically Engineered (GE) Animals ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Amendment on GE Salmon Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---Labeling ---The One Health Act (Sen. Franken Discussion Draft) North American Free Trade Agreement (NAFTA) Renegotiation ---Ag-Biotech Provisions One Health ---The One Health Act (Sen. Franken Discussion Draft) Potential Regulation of New Genetic Modification Technologies Review and Labeling of Food Derived From Biotechnology ---Implementation of Disclosure Law Review of the Federal Coordinated Framework for Biotechnology Products USDA/APHIS Agricultural Biotechnology Regulations ---Efficient Science-Based Review of Biotech Products ---Farm Bill Reauthorization ---Potential Revisions to Part 340 Regulations

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Treasury, Dept of; Office of Management & Budget (OMB); White House Office; Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Environmental Protection Agency (EPA)

Bills named: H.R. 1029 (115th)

Trade (domestic/foreign) TRD

Biosimilars ---Brazil Biologics Regulations ---India Biologics Regulations ---Mexico Biologics Regulations Drug Importation ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 771: Improving Access to Affordable Prescription Drugs ---S.469: Affordable and Safe Prescription Drug Importation Act ---Welch Amendment to: H.R. 2430: FDA Reauthorization Act of 2017 ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Foreign Agricultural Biotechnology Laws and Regulations ---Asynchronous Approvals ---China Biotechnology Regulations ---EU Ag-Biotech Policies and Regulations Intellectual Property International Enforcement ---Compulsory Licensing ---India North American Free Trade Agreement (NAFTA) Renegotiation ---Ag-Biotech Provisions ---IP Provisions ---Pricing and Reimbursement Provisions ---Regulatory Harmonization UN High Level Commission on Access to Medicines ---IP Proposals World Health Organization (WHO) Cancer Resolution ---Pricing and IP Language Foreign Drug Data Protection Laws ---Israel Trade and Foreign Drug Price Controls

Contacted: Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Treasury, Dept of; Patent & Trademark Office (PTO); White House Office; Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Natl Economic Council (NEC); U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Security Council (NSC)

Bills named: S. 934 (115th), S. 771 (115th), S. 469 (115th), H.R. 2430 (115th)

Taxation/Internal Revenue Code TAX

Antibiotic & Diagnostic Tax Credit ---H.R. 1840: Reinvigorating Antibiotic and Diagnostic Innovation Act of 2017 Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension Capital Formation Investment Incentives ---An Act to Modify Net Operating Loss Carryforwards (House Discussion Draft) ---H.R. 2297: PARTNER Act ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules Orphan Drug Issues ---Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit ---Production Tax Credit ---Expansion of Master Limited Partnerships to Renewable Chemicals ---HR 3149: Renewable Chemicals Act of 2017 Research & Development Tax Credit Reforms ---Refundable R&D Credit Treatment of Financial Interests as Stock or Indebtedness ---Section 385 Proposed Regulations Corporate Tax Reform

Contacted: Natl Security Council (NSC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Commerce, Dept of (DOC); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Treasury, Dept of; Securities & Exchange Commission (SEC); White House Office; U.S. Trade Representative (USTR); Natl Economic Council (NEC)

Bills named: H.R. 2297 (115th), H.R. 1840 (115th), H.R. 3149 (115th)

Copyright/Patent/Trademark CPT

Intellectual Property International Enforcement ---Compulsory Licensing ---India Inter Partes Review ---Implementation of the America Invents Act of 2011 --S. 1390: STRONGER Patents Act Patent Reform ---Patent Litigation Reforms ---S. 1390: STRONGER Patents Act Patenting of Biological Inventions ---Argentina Biotech Patentability Guidelines ---Section 101 Modernization UN High Level Commission on Access to Medicines ---IP Proposals World Health Organization Cancer Resolution ---Pricing and IP Language

Contacted: Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Natl Economic Council (NEC); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; Agriculture, Dept of (USDA); White House Office; Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Treasury, Dept of; Commerce, Dept of (DOC); Natl Security Council (NSC)

Bills named: S. 1390 (115th)

Small Business SMB

Capital Market Enhancements ---Accredited Investor Definition ---Fair Investment Opportunities for Professional Experts Act (House Discussion Draft) ---H.R. 1312/S.416: Small Business Capital Formation Enhancement Act ---H.R. 1343/S.488: Encouraging Employee Ownership Act ---SEC Rule 701 ---SEC Small Business Forum Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions ---H.R. 10: Financial CHOICE Act Proxy Advisory Services ---Corporate Governance Reform and Transparency Act (House Discussion Draft) ---H.R. 10: Financial CHOICE Act ---Impact of Policies on Small Public Companies Reform of SEC Regulation D ---Accredited Investor Certification ---H.R. 10: Financial CHOICE Act ---H.R. 79/S. 588: HALOS Act Sarbanes Oxley Section 404 (b) ---H.R. 10: Financial CHOICE Act ---H.R. 1645: Fostering Innovation Act ---Small Issuer Exemption Short Selling Transparency XBRL Exemption for Small Public Companies ---H.R. 10: Financial CHOICE Act ---Small Company Disclosure Simplification Act (House Discussion Draft)

Contacted: Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Natl Security Council (NSC); Commerce, Dept of (DOC); SENATE; Treasury, Dept of; Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); White House Office; Agriculture, Dept of (USDA)

Bills named: S. 488 (115th), H.R. 1645 (115th), H.R. 10 (115th), H.R. 1312 (115th), H.R. 1343 (115th), S. 588 (115th), H.R. 79 (115th), S. 416 (115th)

Medicare/Medicaid MMM

Medicaid ---Average Manufacturer Price Calculations ---Drug Benefit Design ---Pricing and Rebates Reimbursement for Innovative Products ---Medicare Part B Physician-Administered Products ---Medicare Part D Prescription Drug Program ---S. 771: Improving Access to Affordable Prescription Drugs ---Third Party Support of Patient Premiums and Cost-Sharing Obligations ---Value-based Contracting and Communications

Contacted: White House Office; Natl Economic Council (NEC); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Health & Human Services, Dept of (HHS); SENATE; Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR)

Bills named: S. 771 (115th)

Budget/Appropriations BUD

Energy Basic Research Funding ---Advanced Research Projects Agency - Energy ---DOE Office of Science ---Energy and Water Development and Related Agencies Appropriations Act for FY 2018 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---Department of Defense Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Biofuels ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Department of Defense Appropriations Act for FY 2018 ---Department of Defense Funding of Advanced Biofuels ---Energy and Water Development and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization Funding for Biorefineries ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Farm Bill Reauthorization ---H.R.2810: National Defense Authorization Act for 2018 ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program Funding for Antimicrobial Resistance Programs ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for FDA ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Renewable Chemicals/Bio-based Products ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---EPA Safer Choice Program ---Farm Bill Reauthorization ---H.R.2810: National Defense Authorization Act for 2018 ---Reauthorization of USDA Bio-Preferred Program ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance ---Program Funding for the Centers for Disease Control and Prevention Vaccine Programs ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for the USDA ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018

Contacted: White House Office; Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Natl Security Council (NSC)

Bills named: H.R. 2810 (115th)

Chemicals/Chemical Industry CHM

Funding for Renewable Chemicals/Bio-based Products ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---EPA Safer Choice Program ---Farm Bill Reauthorization ---H.R.2810: National Defense Authorization Act for 2018 ---Reauthorization of USDA Bio-Preferred Program ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program Renewable Chemicals/Bio-based Products (Non-Funding) ---Expansion of Master Limited Partnerships to Renewable Chemicals ---Farm Bill Reauthorization ---HR 3149: Renewable Chemicals Act of 2017 ---Investment Tax Credit ---Production Tax Credit ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program ---Reauthorization of USDA Bio-Preferred Program

Contacted: Environmental Protection Agency (EPA); White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Treasury, Dept of; Commerce, Dept of (DOC); Patent & Trademark Office (PTO); SENATE; Natl Economic Council (NEC)

Bills named: H.R. 3149 (115th), H.R. 2810 (115th)

Consumer Issues/Safety/Products CSP

Drug Importation ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---S. 771: Improving Access to Affordable Prescription Drugs ---S.469: Affordable and Safe Prescription Drug Importation Act ---Welch Amendment to: H.R. 2430: FDA Reauthorization Act of 2017 ---S.934/H.R.2430: FDA Reauthorization Act of 2017 Genetically Engineered (GE) Animals ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Amendment on GE Salmon Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---Labeling ---The One Health Act (Sen. Franken Discussion Draft) Review and Labeling of Food Derived From Biotechnology ---Implementation of Disclosure Law

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Treasury, Dept of; Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); Natl Economic Council (NEC); SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Natl Security Council (NSC); Agriculture, Dept of (USDA); White House Office; Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC)

Bills named: S. 771 (115th), S. 934 (115th), S. 469 (115th), H.R. 2430 (115th)

Energy/Nuclear ENG

Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Farm Bill Reauthorization ---Production Tax Credit Extension ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance ---Program Biomass Programs (Non-Funding) ---Farm Bill Reauthorization ---Reauthorization of Biomass Crop Assistance Program ---Reauthorization of Biomass R&D Program Energy Basic Research Funding ---Advanced Research Projects Agency - Energy ---DOE Office of Science ---Energy and Water Development and Related Agencies Appropriations Act for FY 2018 Funding for Biofuels ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Department of Defense Appropriations Act for FY 2018 ---Department of Defense Funding of Advanced Biofuels ---Energy and Water Development and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization Funding for Biomass Crop Assistance Program ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization Funding for Biorefineries ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Farm Bill Reauthorization ---H.R.2810: National Defense Authorization Act for 2018 ---Reauthorization of Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program Renewable Fuel Standard ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Changes to the Point of Obligation under the RFS ---H.R. 1311/S.517: Consumer and Fuel Retailer Choice Act ---RFS Reform ---Proposed Rule for 2018 Volumes

Contacted: Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); SENATE; Environmental Protection Agency (EPA); Treasury, Dept of; White House Office; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Natl Economic Council (NEC); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Natl Security Council (NSC); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 2810 (115th), S. 517 (115th), H.R. 1311 (115th)

Animals ANI

Genetically Engineered (GE) Animals ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Amendment on GE Salmon Labeling ---Efficient Science-Based Review of Biotech Products ---FDA Proposed Guidance on Gene Editing ---Labeling ---The One Health Act (Sen. Franken Discussion Draft)

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Commerce, Dept of (DOC); Treasury, Dept of; Natl Security Council (NSC); U.S. Trade Representative (USTR); SENATE; Natl Economic Council (NEC); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA)

Homeland Security HOM

Biodefense Research, Development, and Procurement Issues (Nonfunding) ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Implementation of Medical Countermeasures Innovation Act ---Tropical Disease Priority Review Voucher (PRV) Program ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---Department of Defense Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Treasury, Dept of; Natl Economic Council (NEC); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); White House Office; Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; SENATE; Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Natl Security Council (NSC)

Bills named: S. 934 (115th), H.R. 2430 (115th)

Medical/Disease Research/Clinical Labs MED

Biodefense Research, Development, and Procurement Issues (Nonfunding) ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Implementation of Medical Countermeasures Innovation Act ---Tropical Disease Priority Review Voucher (PRV) Program ---S.934/H.R. 2430: FDA Reauthorization Act of 2017 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement ---Department of Defense Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for Antimicrobial Resistance Programs ---Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 Funding for National Institutes of Health ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018 ---Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2018

Contacted: Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); SENATE; Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Natl Security Council (NSC); Treasury, Dept of; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Commerce, Dept of (DOC); Patent & Trademark Office (PTO)

Bills named: S. 934 (115th), H.R. 2430 (115th)